LAURUSLABSPharmaceuticals
Laurus Labs Ltd — PE Ratio & Valuation Analysis
₹992.70
-1.44%
Current P/E81.25xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E105.9x23.3% below avg
⚠️
155.7% Premium to Industry
LAURUSLABS P/E 81.25x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹6.64 | ₹1108 | 166.9x |
| 2024 | ₹2.97 | ₹603 | 202.9x |
| 2023 | ₹14.64 | ₹430 | 29.4x |
| 2022 | ₹15.35 | ₹375 | 24.4x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Laurus Labs Ltd Valuation
Laurus Labs Ltd (LAURUSLABS) currently trades at 81.25x earnings. The Pharmaceuticals sector average PE is 31.77x. LAURUSLABS commands a premium, reflecting high growth expectations. Historically, LAURUSLABS has traded at an average PE of 105.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
7.45%
Dividend Yield
0.12%
More on Laurus Labs Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.